ESC Premium Access

LDL-c guidance on the novel ESC/EAS dyslipidaemia guidelines: expert discussions on practical implications

Event: ESC CONGRESS 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Organised by PACE-CME, supported with educational grants provided by Amgen, Pfizer and Sanofi-Regeneron
Date: 3 September 2019
Time: 13:00 - 14:00

Congress Session

5 presentations in this session

Introduction

Speaker: Professor J. Kastelein (Amsterdam, NL)
Thumbnail

LDL-c targets in the ESC-EAS dyslipidaemia guidelines in a nutshell

Speaker: Professor B. Ference (Cambridge, GB)
Thumbnail

A transatlantic discussion on the new LDL-c guidelines - What are the key differences?

Speaker: Doctor C. Ballantyne (Houston, US)
Thumbnail

Discussant perspective on the practical implications of the new ESC/EAS dyslipidaemia guidelines

Speaker: Professor B. Nordestgaard (Copenhagen, DK)
Speaker: Professor J. Kastelein (Amsterdam, NL)
Thumbnail

Challenge the experts - Panel and audience discussion

Speaker: Professor J. Kastelein (Amsterdam, NL)
Thumbnail

6 speakers from this session

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
27 presentations
1 follower

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
16 presentations
1 follower

Professor Borge Nordestgaard

Copenhagen University Hospital - Herlev Gentofte, Copenhagen (Denmark)
8 presentations
2 followers

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

This platform is supported by

logo Novo Nordisk